Clinical Trial Update: Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate [Phase 2]

View source ↗

Summary

A Phase 2 trial updating on combining pirfenidone with mycophenolate for scleroderma-associated interstitial lung disease has completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma
• Systemic Sclerosis with Interstitial Lung Disease

Drugs mentioned

• MycoPhenolate (mycophenolate mofetil)
• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Michael Roth | Conditions: Scleroderma, Systemic, Interstitial Lung Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-12-15